As the patents for "blockbusters"—drugs with annual sales exceeding $1 billion (approximately 1.4 trillion won)—approach ...

A new study published in the journal of Pediatric Dermatology revealed that treatment with dupilumab achieved effective ...

During the cold winter months, many people notice their skin’s condition worsens. Dry air and indoor heating can exacerbate symptoms of eczema, or atopic dermatitis. This leads to dry, cracked ...

Psoriasis is a common inflammatory skin disease linked to several long-term health conditions, such as heart disease, ...

Topical pumecitinib 3% gel shows strong efficacy and good tolerability in mild-to-moderate atopic dermatitis. Explore the ...

Oncodermatology is evolving with nonsurgical approaches and immune checkpoint inhibitors, improving outcomes in aggressive ...

Most patients expressed an interest in understanding how environmental-climate factors affect their atopic dermatitis.

Amlitelimab is effective at improving moderate to severe AD across all body regions, including the difficult-to-treat head and neck region.

INDICATIONS ZORYVE cream, 0.05%, is indicated for topical treatment of mild to moderate atopic dermatitis in pediatric patients 2 to 5 years of age. ZORYVE cream, 0.15%, is indicated for topical ...